A single-session, telehealth pain relief skills class did not help reduce opioid use in adults with chronic pain, though it modestly improved mental health.

Increasing postoperative step counts after inpatient surgery may help lower the risks for complications and readmission.

Pregestationally assessed cardiometabolic biomarkers may help identify women at increased risk for hypertensive disorders of pregnancy.

Serious infection risk in older adults with RA appears to be driven more by modifiable clinical factors rather than the age at which RA develops.

The FDA has approved Immgolis and Immgolis Intri (golimumab-sldi), the first interchangeable biosimilars for Simponi and Simponi Aria to treat RA and UC.

FDA issues safety alert for expired Amazon Basic Care Levonorgestrel 1.5mg tablets distributed between January 24, 2025 and April 29, 2026.

Abdominal obesity is associated with a higher prevalence and greater severity of menopausal symptoms, according to results of a recent study.

Treatment with semaglutide significantly improves measures of motivation in patients with major depressive disorder.

Response to febuxostat differed based on hyperuricemia subtype in older patients with gout, with the combined subtype linked to the lowest rates of SU target achievement.

Results of a longitudinal analysis suggest that specific long-chain PFAS may play a role in both the development and symptomatic worsening of knee OA.

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

The EULAR released a 2025 update to the 2018 recommendations for physical activity among individuals with IA or OA, with an emphasis on reducing sedentary behavior.